{"ticker": {"uuid": "1a164209-59d6-4dce-90d4-9a9b0789fa25", "symbol": "EVH", "name": "Evolent Health Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026", "summary": "Evolent Health, Inc. announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open. A conference call will follow at 8 a.m. ET, accessible via Evolent's investor relations website, and an audio playback will be available for 9", "url": "https://www.sahmcapital.com/news/content/evolent-to-release-second-quarter-2026-financial-results-on-thursday-august-6-2026-2026-07-08", "source_name": "Sahm", "published_at": "2026-07-09T02:40:48", "published_display": "09 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent set to report Q2 2026 results before Aug. 6 call", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUm9zR2dXc1M0dHJYRjQtTzV0TTQ5MkZzeVAtU2wtelZQazVmazdZbGdzYWp3c1hUVU1VUE93QUd2blRjU2VibzFVaDM3OVg4cmNUZFhINHhmSzRLeWN4RzQyOFhDRmRRZFhOVk5VRVRrSWpMVFVXYmxycnAwSmdqMkcxMzBhMFJiTjFmbWpCaGh3THkzZWhYRFM4RGpjSUc0emI0UnV1bElCM0dWdzl1TGROcHFVazlfS1JybWJFRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-08T20:30:00+00:00", "published_display": "08 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) president receives 302,585 RSUs in equity grant", "summary": "Evolent Health, Inc. president Daniel McCarthy was granted 302,585 restricted stock units (RSUs) as part of an equity compensation package approved by the Compensation Committee. These RSUs will vest in three tranches on July 1, 2027, 2028, and 2029. In connection with this grant", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-7365f5a0fb39.html", "source_name": "Stock Titan", "published_at": "2026-07-07T14:39:50", "published_display": "07 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) CEO gets 446,102 RSUs and has shares withheld for taxes", "summary": "Evolent Health, Inc.'s CEO, Seth Blackley, was granted 446,102 restricted stock units (RSUs) with a vesting schedule extending to 2029. To cover tax obligations upon the vesting of these RSUs, 10,297 shares of Class A Common Stock, valued at $5.74 per share, were withheld. Follow", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-b5aedcf4c430.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:48", "published_display": "06 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) General Counsel receives RSU grant with tax-withholding entry", "summary": "Evolent Health's General Counsel, Jonathan Weinberg, received a grant of 43,055 restricted stock units (RSUs) on July 1, 2026, as part of his annual equity compensation. Concurrently, 2,650 shares were withheld to cover tax obligations upon the vesting of previously granted RSUs,", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-d8ab7421a9eb.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:48", "published_display": "06 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) grants 28,790 RSUs to Chief Accounting Officer", "summary": "Evolent Health, Inc. (EVH) has granted 28,790 restricted stock units (RSUs) to its Chief Accounting Officer, Shams Aammaad, under the company's 2015 Omnibus Incentive Compensation Plan. These RSUs will vest in tranches: 34% on July 1, 2027, and 33% on both July 1, 2028, and July ", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-9dda505d3844.html", "source_name": "Stock Titan", "published_at": "2026-07-06T19:41:48", "published_display": "06 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health focuses on value-based care as investors watch long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPUmxBSHU4b0xRS3RGcTlGWk5HMTJRaHBGSnQwRnl0MkdLWXppZnVOX1FVY0JvaFZJV25EejBLZzNDd28xZkMxcjJVVncwcm9YbHhScjFITUQwRWxGQzA5WTB0QVEwUDBJNzlSZVV0WUNhdjgxc2lvTmlsZlhkZHNzX0JPdklCRGJYcVVQTndxM2l2MUJmUHFXNDRMSXF0Y2VxNUp3MXpsWEM0d3pCTDhjbldYQlI1UHFYTF8tUFA3N1FVVG1taGlJSXNR?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T17:06:21+00:00", "published_display": "06 Jul 2026 17:06", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Evolent Health (EVH) After Golden Cross?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOYmFaWnlzOGY5elQxSUFTbUJQUktvOFFLdmdfb1JwUmhNVUZ2T0czV096QUlsY0xoMG5oek1ILUhYcTRwVTFVSXJQSVhrQ0poa2I1RXdPYkEwNEUwR3d5VmZ5cDhMa2I2azhrMUM1RmxYSFJSZmpJcXVrRHQ0RlVRZlI3TVg?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-03T13:55:02+00:00", "published_display": "03 Jul 2026 13:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Downgrades Evolent Health to Hold From Buy, Keeps $7 Price Target, Cites Recent Share Price Strength, Medicaid Headwind", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-downgrades-evolent-health-hold-104058302.html", "source_name": "MT Newswires", "published_at": "2026-06-30T10:40:58+00:00", "published_display": "30 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPZkR0MXhWOUV4bFowVjhYRnFYc2tfVTJjV3VfVjgtR0hCVHlKV2FLbzBxZFpBeDR4QTc3emhnbUgxdVAtU1R3bWVHcmVUN1dEdHc5WkU1ZUEwSEV2azJiSUgtT1UtOXpCOGpqU3pkSDRKbEw5YzcyMUFyYk1heW8wdzQ3bzNEUjN4MWpVSndVSWVIek9IdmhUTTAwdHI3Zw?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Evolent Health Inc Class A \u2013 FWB:9EH", "summary": "This page provides financial data for Evolent Health Inc Class A (FWB:9EH) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades recorded. The data is presented within the Tr", "url": "https://www.tradingview.com/symbols/FWB-9EH/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T11:10:50", "published_display": "27 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Evolent Health Inc Class A \u2013 FWB:9EH", "summary": "This article provides the \"Price to sales forward\" metric for Evolent Health Inc Class A (FWB:9EH) on the Frankfurt Stock Exchange. It appears to be a financial data point from TradingView, indicating a specific valuation ratio for the company over a given period, along with its ", "url": "https://www.tradingview.com/symbols/FWB-9EH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T10:11:20", "published_display": "27 Jun 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH)", "summary": "This article provides an overview of Evolent Health, Inc. (EVH) stock, including current market data, analyst forecasts, and detailed financial information. It covers the stock's price performance, market capitalization, earnings, revenue, and EBITDA, along with frequently asked ", "url": "https://www.tradingview.com/symbols/NYSE-EVH/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T03:10:08", "published_display": "26 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health says sale refocuses telehealth business, cuts costs", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0x6M0VNYlFDNFVkamJTZXVTMTNPYU92VG9vYzE4U2JLMlJqM1FYdnQ3dHFOcmt0MlhZSENXekdsSGt3UVFGeVZKaUFrWlNJYThVUmtXOE1ETGdWbDlLYUt1anltSVlrUmg2ZXVpMkp6eG9NZDA1TzJvTXJKbFE2bnJlRm84UWM4MEpMNUZ6RTU5WDRUaXpCU2VGRnNpYk9ERWRCVkZRblBEM2VPdWxTMGhDMEVVM28zbkpYQw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH) and Celldex (CLDX)", "summary": "This article highlights bullish sentiments from financial analysts on three healthcare companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH), and Celldex (CLDX). UBS reiterated a Buy rating for Amneal Pharmaceuticals, while Truist Financial maintained a Buy rating for Ev", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CLDX/pressreleases/2453853/analysts-offer-insights-on-healthcare-companies-amneal-pharmaceuticals-amrx-evolent-health-evh-and-celldex-cldx/", "source_name": "The Globe and Mail", "published_at": "2026-06-14T06:40:17", "published_display": "14 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Raises Price Target on Evolent Health to $7 From $6, Keeps Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-raises-price-target-evolent-094013572.html", "source_name": "MT Newswires", "published_at": "2026-06-12T09:40:13+00:00", "published_display": "12 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQZFR4dW9fZzRnSGhnTjljTlVXZnRsWTUwemRBR1ZtTTVBaHVjVkNXUE5DMnhRNG9jd0lPZjZhcWR2elVwemZ1U1FCTTRoZGtBN0VjdGJ5NzlhazlWR0RNOEhCYVZPVWNmVkZvM29fOUZrUGZaXzVRNkh6T3NQTGhmZGN3RWNuaDhPYVU3QkNGS09SUUpmRGRHTnV0dWNkMjVjT1Y2WlpOaE9lNUI1dWc?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units", "summary": "Evolent Health, Inc. director Russell Monroe Glass was granted 41,096 restricted stock units (RSUs) of Class A Common Stock at $0.00 per share under the company\u2019s 2015 Omnibus Incentive Compensation Plan. These RSUs are set to vest on the earlier of June 4, 2027, or the company's", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-947f29717cec.html", "source_name": "Stock Titan", "published_at": "2026-06-11T18:09:22", "published_display": "11 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Evolent Health (EVH) receives 41,096-share RSU grant", "summary": "Evolent Health director Brendan B. Springstubb was granted 41,096 restricted stock units (RSUs) of Class A Common Stock, valued at $0.00 per share, under the company's 2015 Omnibus Incentive Compensation Plan. Following this grant, his direct holdings total 99,917 shares. These R", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-b6bba4b2d6bf.html", "source_name": "Stock Titan", "published_at": "2026-06-09T11:10:10", "published_display": "09 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director receives 41,096 restricted stock units grant", "summary": "Evolent Health, Inc. director Peter J. Grua was granted 41,096 restricted stock units (RSUs) of Class A Common Stock at $0.00 per share, as reported in a Form 4 filing. These RSUs are compensation-related and will vest on the earlier of June 4, 2027, or the company's 2027 annual ", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-58af23ce219f.html", "source_name": "Stock Titan", "published_at": "2026-06-09T03:08:43", "published_display": "09 Jun 2026 03:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units", "summary": "Evolent Health director Kim Keck was granted 41,096 restricted stock units (RSUs) under the company's 2015 Omnibus Incentive Compensation Plan, increasing her direct ownership to 102,597 shares. These RSUs will vest on the earlier of June 4, 2027, or the company\u2019s 2027 annual mee", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-4409002253d4.html", "source_name": "Stock Titan", "published_at": "2026-06-09T02:09:28", "published_display": "09 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings", "summary": "Evolent Health director Craig A. Barbarosh was granted 41,096 restricted stock units (RSUs) as part of the company's 2015 Omnibus Incentive Compensation Plan, at no cash cost. These RSUs are set to vest by June 4, 2027, or the company's 2027 annual meeting, contingent on his cont", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-c04cc6f0a6d7.html", "source_name": "Stock Titan", "published_at": "2026-06-09T00:09:28", "published_display": "09 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director receives 41,096 restricted stock units award", "summary": "Jill D. Smith, a director at Evolent Health (EVH), was granted 41,096 restricted stock units (RSUs) as equity compensation, increasing her total direct holdings to 64,233 shares. These RSUs, part of the 2015 Omnibus Incentive Compensation Plan, will vest on the earlier of June 4,", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-9bd2c919f2aa.html", "source_name": "Stock Titan", "published_at": "2026-06-08T20:09:28", "published_display": "08 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Evolent Health, Inc. Insider Trading Activity", "summary": "Evolent Health, Inc. director Shawn M. Guertin reported receiving an equity award of 41,096 restricted stock units of Class A Common Stock. These units were granted at no cash cost under the company's 2015 Omnibus Incentive Compensation Plan and vest on the earlier of June 4, 202", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-be078ff1f7fb.html", "source_name": "Stock Titan", "published_at": "2026-06-08T20:09:28", "published_display": "08 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant", "summary": "Richard M. Jelinek, a director at Evolent Health (EVH), received an equity grant of 41,096 restricted stock units (RSUs) with no purchase price. These RSUs will vest on the earlier of June 4, 2027, or the company's 2027 annual meeting, provided Jelinek continues his service. Foll", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-a7b9c359eaff.html", "source_name": "Stock Titan", "published_at": "2026-06-08T20:09:28", "published_display": "08 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) holders back board, auditor and pay plan at 2026 meeting", "summary": "Evolent Health (EVH) stockholders approved all proposals at their 2026 annual meeting, including the election of ten director nominees, the ratification of Deloitte & Touche LLP as their independent registered public accounting firm, and an advisory vote on 2025 executive compens", "url": "https://www.stocktitan.net/sec-filings/EVH/8-k-evolent-health-inc-reports-material-event-170cf49fe7a5.html", "source_name": "Stock Titan", "published_at": "2026-06-04T19:38:39", "published_display": "04 Jun 2026 19:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxORE9OaWtsRXhXVG1pb1k1OE55LTR4RXBWbUthTDBzSUMwdEZZcGdhUHNQdmFQeWIwbUlsYWNGZlVHVnNQTFF1Z0ZTUXBmME5tOVI1UjRtbTBkMC1Gc092TFRRUGpRaXJmMnhSTWRFS1FCYkIyeU1FbU5Hc1ZjOGtOZENWOUJuSEdjbGJIQjBPZmNhSy1GRVh1bTRDd0JKLWN3U0VoQi1YZEpjcTBKaUFvMzRxSENzUjdSR1VjT3o3V1gySXJXTHVTdzhzQ1NjWEMybnRNVHJIby1YanRt?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?", "summary": "", "url": "https://finance.yahoo.com/m/dc8aa335-0a27-3c66-b23b-bf6a169ec69b/is-privia-health-stock-a-buy.html", "source_name": "Motley Fool", "published_at": "2026-05-30T20:27:35+00:00", "published_display": "30 May 2026 20:27", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health : EVH", "summary": "Evolent Health Inc. (EVH) specializes in healthcare management, offering services in oncology, cardiology, and musculoskeletal care, backed by its Identifi technology. The company, founded in 2011 and based in Arlington, Virginia, supports health plan administration and provides ", "url": "https://247wallst.com/companies/evh/", "source_name": "24/7 Wall St.", "published_at": "2026-05-20T08:10:38", "published_display": "20 May 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts\u2019 Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH)", "summary": "Analysts from Maxim Group and William Blair have issued bullish sentiments on ProMIS Neurosciences (PMN) and Evolent Health (EVH) respectively. ProMIS Neurosciences received a Buy rating with a $35.00 price target, while Evolent Health also maintained a Buy rating with a consensu", "url": "https://www.theglobeandmail.com/investing/markets/stocks/PMN/pressreleases/1979495/analysts-top-healthcare-picks-promis-neurosciences-pmn-evolent-health-evh/", "source_name": "The Globe and Mail", "published_at": "2026-05-17T04:39:22", "published_display": "17 May 2026 04:39", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Earnings: Here's What Analysts Think", "summary": "Evolent Health, Inc. (NYSE:EVH) recently reported first-quarter earnings, with shares surging 14%. While revenues came in below estimates, statutory losses were smaller than predicted. Analysts maintain a consensus price target of US$5.43, with expectations for significant revenu", "url": "https://www.sahmcapital.com/news/content/evolent-health-inc-nyseevh-just-released-its-first-quarter-earnings-heres-what-analysts-think-2026-05-09", "source_name": "Sahm", "published_at": "2026-05-09T13:40:06", "published_display": "09 May 2026 13:40", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) Narrows Q1 Loss To US$26.6 Million Testing Bullish Margin Narratives", "summary": "Evolent Health (EVH) reported a Q1 2026 net loss of US$26.6 million on US$496.2 million in revenue, narrowing its loss from the previous quarter but still operating in loss-making territory. Analysts anticipate significant long-term margin improvement and profit, heavily relying ", "url": "https://www.sahmcapital.com/news/content/evolent-health-evh-narrows-q1-loss-to-us266-million-testing-bullish-margin-narratives-2026-05-08", "source_name": "Sahm", "published_at": "2026-05-09T01:39:16", "published_display": "09 May 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (NYSE: EVH) trims Q1 2026 loss as revenue tops $496M", "summary": "Evolent Health (NYSE: EVH) reported a narrower net loss of $26.6 million for Q1 2026, a significant improvement from the $72.3 million loss in Q1 2025, with revenue climbing to $496.2 million. The company's basic and diluted loss per share decreased to $0.24, compared to $0.63 in", "url": "https://www.stocktitan.net/sec-filings/EVH/10-q-evolent-health-inc-quarterly-earnings-report-aa4e73d1eb68.html", "source_name": "Stock Titan", "published_at": "2026-05-07T12:39:15", "published_display": "07 May 2026 12:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent (NYSE: EVH) trims Q1 2026 loss as costs rise, keeps outlook", "summary": "Evolent Health, Inc. reported slightly increased Q1 2026 revenue of $496.2 million, with net loss narrowing to $26.6 million. However, adjusted EBITDA declined due to rising medical costs, reflected in a higher medical expense ratio of 93.3%. The company reaffirmed its full-year ", "url": "https://www.stocktitan.net/sec-filings/EVH/8-k-evolent-health-inc-reports-material-event-533eb8fc2fb4.html", "source_name": "Stock Titan", "published_at": "2026-05-07T11:10:16", "published_display": "07 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Evolent Health (EVH) Stock Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQR1ZBTEVDYWhWdjBQd0Nqb0xtQTJCMERqdWtiWmpQX3RscEpMd2hqSmFYUkhlY1hMdDRscWZqQXFLY3JobkQ0VWdxRXgxQl93dVpMOXZtTUxUU3A3c2VDSm1iM25wMUwtRWpqc1FBMlUxOHlrTVFVelBEbmlaVUZNV0NKdDJBTU44YnlaWDFhMlpZMVY3cW5yZWtDb1ZFTGJGMGZkNUVIaw?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOZmxLUHpkdHI0UnIyTjZXa0tmUklocXVQUVNxOEpGY0s2SmRtTlR4UTB1T0lhTnFiRVl4b3RBVkNoTkpQNFBYQTBEYnItT043dFY0SFVEd2NleE0xVGEtOGhkNWxtbTFHRWwwOEpoSHo0NnBqUnFuTU44S2lBY240UUhhS0t5a2JaSmpuTU8tUnFZVnN0SW5SS3lmbTJCanRrVXM5MXFrRkRoa25YTENDRUprYkVSQXBqMllqMFJHRHhsMDVRelZjdVVmZDloT1phdThDWklR?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Announces First Quarter 2026 Results", "summary": "Evolent Health, Inc. announced its financial results for the first quarter ended March 31, 2026, reporting revenue of $496.2 million and a net loss attributable to common shareholders of $26.6 million. Despite a net loss, the company reiterates its full-year 2026 revenue guidance", "url": "https://www.sahmcapital.com/news/content/evolent-announces-first-quarter-2026-results-2026-05-07", "source_name": "Sahm", "published_at": "2026-05-06T17:39:18", "published_display": "06 May 2026 17:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Evolent Health (EVH) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQT210WUZxQ2tXcmJURVpCZ2ZuOUhRTFQtZk9EZm9JM0pLX2dWaXYzT1pJaE5ObjdNcTh1dnNFNkFVMFF2Y3BnaEo1OTA3Y21tZ2owY3pOZE52Q2l6T1BjVWVnX2xqR3RKbHA2UDdESExQNkM5dHRPWXRkbjlXel9FWnZKb3RpVjdIbDk5SlRCdGZyN3FQMkpfMQ?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxOb1JsNjROdDgwZm1PaXVMSWhxM0hTd216cXBYU0xTQmNKQm8zU2I0bzdyUTdBRVJ5STd1eDA1cEhQQk1oVk1WNnFRMVhvajVwZjZ4d3Z4UERabUxORFlYNzFUMXowSXFWb1d1dWZmcUUwRnR3cjBRc0VEaTctQVlOc25lMWpwVk1qR3lwUTRtT2Fuel9acHFvaGNVSzVIcF8wZTcwUFY2OTFaWTd3cnlfSjRVS0NveUtsV1Y4ZGZSZFp3OXNoX2kwNnc4X3ZBbmtsbTVCMFJyZVNRQ3cwVVphdm9B?oc=5", "source_name": "StockStory", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxQanFhNFBobUhvWlBzcGxQN21VUzlqZW45RmtYWk1sbTVnSUxiTWxScHd3MTRQTzJUak9uVjd0UWZiSFExMmlUNW9wekdBb3pmZ0JsRlI5MXRwOTJiYzM5Y2ZnNXVFblRzMTdCVFg0eEM3TGxvckdGcnZxZGxzVl9PZW5DbDR3N2R5RHlyeHhKSUxublE3MzRScDUzVWdEUVgtdVdEMVhBMHhmVHlxQ2RzTjJaUXZ2cHJYQU1fS0dpMldJLXhLSDZjNW5TUTRmbDk2LWRPQWM5TjZTSzB6bHJFeC1nVHl3TV9ncTRHandYUk96U28?oc=5", "source_name": "StockStory", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026", "summary": "Evolent Health, Inc. (NYSE: EVH) announced that it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open. A conference call for shareholders and interested participants will follow at 8 a.m. ET, accessible via Evolent's investor relati", "url": "https://www.sahmcapital.com/news/content/evolent-to-release-first-quarter-2026-financial-results-on-thursday-may-7-2026-2026-04-07", "source_name": "Sahm", "published_at": "2026-04-08T12:40:02", "published_display": "08 Apr 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQbmJvTlduSGVKcFlkS0paQWdDTVA2cHNBbTBNYnlfN25QOHpDX0NtUFRjSmF5MjJLbWw4al9sbFNMT3FrOE9IeThaZkExMkFZNVUxem9CNktXMk9RSjJ6R3hsa1ZLVFBnUlR5c25aNXk0cFZ1UkM2b2U3THdfeFA2cGNIMGl2R3BwQlJuV1Rld1ctcFUxNTJz?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQWndTWUFkaVhCWkFYMUQ0UkdvQjZTUUJJZ2V6dUdBZUwxNjlySGliOF9PTlRkS2tsRWNXcG9MRjJnT1pYTERyTTh6T09veW0tVUl2Q1ZkM1dQVGpsRUVsdDR3eDBJc3h6NkllZEtpcHJ4NnVaUVpOQmt5LWRLNnB5cHZCU0VqNWxMaFQ5VFg0YWNVbFV5eV81NUlyVW85TzJHQlQwWnFn?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G/A] Evolent Health, Inc. Amended Passive Investment Disclosure", "summary": "The Vanguard Group filed an Amendment No. 8 to a Schedule 13G/A for Evolent Health, Inc. (EVH), reporting that its beneficial ownership is now 0 shares (0%) due to an internal realignment. This realignment, effective January 12, 2026, means certain Vanguard subsidiaries will now ", "url": "https://www.stocktitan.net/sec-filings/EVH/schedule-13g-a-evolent-health-inc-amended-passive-investment-disclosu-7b06abf5039f.html", "source_name": "Stock Titan", "published_at": "2026-03-24T11:41:06", "published_display": "24 Mar 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent announces appointment of Archie Mayani as chief product officer", "summary": "Evolent Health, Inc. has announced the appointment of Archie Mayani as Chief Product Officer. Mayani brings over two decades of experience in healthcare technology and AI, having previously held leadership roles at GHX, Change Healthcare, UnitedHealth Group, and Amazon. Her exper", "url": "https://www.sahmcapital.com/news/content/evolent-announces-appointment-of-archie-mayani-as-chief-product-officer-2026-03-19", "source_name": "Sahm", "published_at": "2026-03-19T17:41:19", "published_display": "19 Mar 2026 17:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Small-Cap Stock Risks: Declining Demand at Luxfer & Financial Strain at Evolent Health - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORTA5dFl6TEJhaEhhTVdpU0hsdnR5SkxxcGtZWWQwaEV2dWV2ZEVSazVqYmhwdmhxMnh5MXE2ZFFrNjFaMUl6aXc0M3hIcS1VSUhXeGFucW1ZbF91czd0QkhCLTF2Nl9oMlhTUlN1dU81UG1SZEFoQUZXVTU4ZFVtM2dzckMyLXpUY3FQdGduRkVqTkJ4TTNMQV9QV1VGb0VvTGoyX0hvaDVyMXNOV1UzSG05RFQ4cHc?oc=5", "source_name": "IndexBox", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EVH Stock Price, Quote & Chart | EVOLENT HEALTH INC - A (NYSE:EVH)", "summary": "This article provides an overview of Evolent Health Inc. (EVH) stock, including its current price of $2.99, recent performance, and key financial metrics. The company reported Q4 earnings recently, beating EPS expectations but missing revenue, and analysts forecast a significant ", "url": "https://www.chartmill.com/stock/quote/EVH/profile", "source_name": "ChartMill", "published_at": "2026-03-12T23:51:34", "published_display": "12 Mar 2026 23:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How to listen to Health Catalyst\u2019s March 12 results call", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOT3JfOVF2X3hWZ1BFdmRQVHVCalJuSlRGR1A4Vm1zYml0X2t5WkZKNjlFNy1PcWR1djlBZjdPb0ZrVEtURXBCVWhsaHAwWEoxalUxdzZqOEE4V3lBYU9qTk1MZW5WMjduOWNJd25UOXBKR0FyNDdyQXdpMmNrRnIyS2ZRVDZSOVFTZVYya2Z1RzlFdEY5dzlxMmNnaWY5OGUzdnZEVWtsTktlMERWM1ZjMVNXUHJFQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) Shares Skyrocket, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOZDRtelRVWHNsMS1wcEN5SjJvZ3dyYkRnTzV6bUNVajZTaGxxa3BPRGdseTlSYW1WeGVPVlVpSmNPRVF0SlMtRkFXdVVVUmFyN05YV3JFQVM2ck9CeXZWMkQ4bEVWQkg2c0RET1NkZ0hFQTcxOEg3MTVnUE9aS3VUVjZIb3dqQmxN?oc=5", "source_name": "Market source", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) Reports Q4: Everything You Need To Know Ahead Of Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ1I5MEdnMC1PazYyZUYtMFBSV2hsaTdrRjVNaGNJRzdzS3Fzb3ljeUhZUGFrczJOdEdDYXdQWUhFQzVwY1BPX3l1cmRDR3NydjZVR1B3N3U2RHhqY3ZpRjROZWJHN2dTeDl0MUFvR3pFRUo0em5PNzItTzhFMjM4cA?oc=5", "source_name": "Market source", "published_at": "2026-02-22T08:00:00+00:00", "published_display": "22 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNSjhLcktHSzEyOEMtaEZpeFlFb0FuWV9UZ0FwRHJ4enVRbVdwQkszVmlRMXZvdnR3dGZ5Q3JhNVhVT3VscXNRSFR2MjNSTy1BZjhTcE1yd3M0d1hialRTT3d2bmkyY3NxSFJhRTVUa1hxX1dXRVpwZ3FHSnN5a28tNmM3aUc?oc=5", "source_name": "Market source", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health, Inc. - Class A Shares (EVH) Stock Price Today: $5.63", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1UNFMtbW1TMFphRVZHRW1hN0M0T05hVEdtVTFVa1VuVkVURU85Z2ZJSjU0dENwaG5raVBiTjViVjdqdGFTUnpuWjBWY1JienF0djdTRVN3?oc=5", "source_name": "Gotrade", "published_at": "2026-02-03T07:00:20+00:00", "published_display": "03 Feb 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Take Care Before Diving Into The Deep End On Evolent Health, Inc. (NYSE:EVH)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Evolent Health (EVH) Shares Are Sliding Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOX3h1eDU4aDRMM0FNNzNDNDAxS0M3R2tkMGJ4YjdhS2VUZVJmV1VicmFJVzh0eGRjZlVwUk9Xd3g5S1pxRzRWT0toTWRwTm45WmcwUHNxVVdqaXhVSENQNEVNaExKTUlidVBYOWF3aEVJNXU0MTV2NXpYVzhUUzE5cA?oc=5", "source_name": "Market source", "published_at": "2025-11-19T08:00:00+00:00", "published_display": "19 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPcGNGXzF5eUNGZ3NIVDBaMXFNLTlnUEFBajJZTFJhVUM0a3ZUNXZWZy1HYXBYdkV1dmNScFZWbTJNbldFVjVFU0dTenVRc1lGeGNIUS1iNV9uSm5acGE1cmhsQ2N5NGxTME9MUHJuT01kLXJXRmgtV1hQekNZMUR0VzFxaHVsSXQ0dndadEVFSmNvSzEzNlF1MUlGVFlyWHJYTE0zVFgxZUsydG5QU0JBUEFfY1RZeUZRLUZidmJCdkhBYTVfRnFzZnNiWmZnTEh5ZXdvR2NKMXBHRXVYT2dKcDUwUF9VUmNKX0NpQUlrYw?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywJBVV95cUxPSzBJWkN5TnV1U2VfR0F6ODh5UW9qYzdVcmxhQzNZZ1VuWm5sd1JKcUcyMld4SjJ1ZGlGSF83WHVVU3lJWkpRVGF1R2NOQmJKOTNiUUtYVWlTbTAzeTBGQk9JWXJrd1BZcXJMdFMzNmpQNGd5NWRWejUwWXBLNUhISFJQalhmZHoxa1RZQW5tWXl3eUFsUUZoWXh5Mm10TXJUOTRObUJZenQ0UjJiLWp1NDdFZ3k0RS05bWRUUzE3Q3llZTNaRmNEN1oyWUFMUEQ2VVFRN2FrNUZKcExReE95eVBaYkd4ZTR0eFJxTHJ2OWx2X1R1TjlXeXVzQzZmS25McUJmM201TnIwamlvdEo4VV9vdndjRktORjJVWXQ1eUF1eGdRUW9NQ2ROQ2NNYlBDWXc3LU9QR1djaE9oMFd6SUdIazkwVVgtN05R?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-19T07:00:00+00:00", "published_display": "19 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Evolent Health (EVH) Stock Is Nosediving", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNVFZkLTI5M0x3X1hwTzBMU1hIOVJRaTV5cEE0eHlhNVFxRUhMSXRLQmQxMFNDdVA0VV9CTUYtUjBfb0lsQkFXMWxJemJqRmpjMDdhS1RacHVmZnFDT3BaWWMtbzRvd09YODVnQlIzR0oyNWFxVEZENDEtOTNvczBwdzNtNXNpQ25reUhMUFFyemphV2k5dTFhOU8xa0I2NVlRRVpV?oc=5", "source_name": "StockStory", "published_at": "2025-08-08T07:00:00+00:00", "published_display": "08 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Privia Health Announces Q2 2025 Earnings Call: Key Details for August 7 Pre-Market Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPcDdGajBYcnBKZERVcy00Ym9aaEx1cFNWYXhUdmxmY0t5R1B5bUUxQnBGTUl1dndCSGZkeUZUS3pZaERfVmhEVjd3TlZBMzduaVFrWjNKaFowNVpydmpQNXpaaS1Rc1Nwb1czekROUFcwem91SmNSSzNMZUFEOU80TDd0eG1SQVlaeEZSY25PbzlvWDNiek9sN3UtZWJjM0ZBUkdpNHd2eUVEQUFDaVF2VUc2WUZLTHRyUnc?oc=5", "source_name": "Stock Titan", "published_at": "2025-07-10T07:00:00+00:00", "published_display": "10 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Streamline Health Solutions In (STRM) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2QmlFQ3laVE9oMXFKazhkeFZOM2FUQ0pGVUthUFlJRGQ3U1dkSXJmcXhoZXpfQi1JbTVJdEgtbmJZWVcyNVdENzNLZ21XOXdRZXhF?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T04:54:57+00:00", "published_display": "25 Apr 2025 04:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026", "summary": "Evolent Health, Inc. announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open. A conference call will follow at 8 a.m. ET, accessible via Evolent's investor relations website, and an audio playback will be available for 9", "url": "https://www.sahmcapital.com/news/content/evolent-to-release-second-quarter-2026-financial-results-on-thursday-august-6-2026-2026-07-08", "source_name": "Sahm", "published_at": "2026-07-09T02:40:48", "published_display": "09 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent set to report Q2 2026 results before Aug. 6 call", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUm9zR2dXc1M0dHJYRjQtTzV0TTQ5MkZzeVAtU2wtelZQazVmazdZbGdzYWp3c1hUVU1VUE93QUd2blRjU2VibzFVaDM3OVg4cmNUZFhINHhmSzRLeWN4RzQyOFhDRmRRZFhOVk5VRVRrSWpMVFVXYmxycnAwSmdqMkcxMzBhMFJiTjFmbWpCaGh3THkzZWhYRFM4RGpjSUc0emI0UnV1bElCM0dWdzl1TGROcHFVazlfS1JybWJFRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-08T20:30:00+00:00", "published_display": "08 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) president receives 302,585 RSUs in equity grant", "summary": "Evolent Health, Inc. president Daniel McCarthy was granted 302,585 restricted stock units (RSUs) as part of an equity compensation package approved by the Compensation Committee. These RSUs will vest in three tranches on July 1, 2027, 2028, and 2029. In connection with this grant", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-7365f5a0fb39.html", "source_name": "Stock Titan", "published_at": "2026-07-07T14:39:50", "published_display": "07 Jul 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) CEO gets 446,102 RSUs and has shares withheld for taxes", "summary": "Evolent Health, Inc.'s CEO, Seth Blackley, was granted 446,102 restricted stock units (RSUs) with a vesting schedule extending to 2029. To cover tax obligations upon the vesting of these RSUs, 10,297 shares of Class A Common Stock, valued at $5.74 per share, were withheld. Follow", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-b5aedcf4c430.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:48", "published_display": "06 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) General Counsel receives RSU grant with tax-withholding entry", "summary": "Evolent Health's General Counsel, Jonathan Weinberg, received a grant of 43,055 restricted stock units (RSUs) on July 1, 2026, as part of his annual equity compensation. Concurrently, 2,650 shares were withheld to cover tax obligations upon the vesting of previously granted RSUs,", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-d8ab7421a9eb.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:41:48", "published_display": "06 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) grants 28,790 RSUs to Chief Accounting Officer", "summary": "Evolent Health, Inc. (EVH) has granted 28,790 restricted stock units (RSUs) to its Chief Accounting Officer, Shams Aammaad, under the company's 2015 Omnibus Incentive Compensation Plan. These RSUs will vest in tranches: 34% on July 1, 2027, and 33% on both July 1, 2028, and July ", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-9dda505d3844.html", "source_name": "Stock Titan", "published_at": "2026-07-06T19:41:48", "published_display": "06 Jul 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health focuses on value-based care as investors watch long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPUmxBSHU4b0xRS3RGcTlGWk5HMTJRaHBGSnQwRnl0MkdLWXppZnVOX1FVY0JvaFZJV25EejBLZzNDd28xZkMxcjJVVncwcm9YbHhScjFITUQwRWxGQzA5WTB0QVEwUDBJNzlSZVV0WUNhdjgxc2lvTmlsZlhkZHNzX0JPdklCRGJYcVVQTndxM2l2MUJmUHFXNDRMSXF0Y2VxNUp3MXpsWEM0d3pCTDhjbldYQlI1UHFYTF8tUFA3N1FVVG1taGlJSXNR?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T17:06:21+00:00", "published_display": "06 Jul 2026 17:06", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Evolent Health (EVH) After Golden Cross?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOYmFaWnlzOGY5elQxSUFTbUJQUktvOFFLdmdfb1JwUmhNVUZ2T0czV096QUlsY0xoMG5oek1ILUhYcTRwVTFVSXJQSVhrQ0poa2I1RXdPYkEwNEUwR3d5VmZ5cDhMa2I2azhrMUM1RmxYSFJSZmpJcXVrRHQ0RlVRZlI3TVg?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-03T13:55:02+00:00", "published_display": "03 Jul 2026 13:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Downgrades Evolent Health to Hold From Buy, Keeps $7 Price Target, Cites Recent Share Price Strength, Medicaid Headwind", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-downgrades-evolent-health-hold-104058302.html", "source_name": "MT Newswires", "published_at": "2026-06-30T10:40:58+00:00", "published_display": "30 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPZkR0MXhWOUV4bFowVjhYRnFYc2tfVTJjV3VfVjgtR0hCVHlKV2FLbzBxZFpBeDR4QTc3emhnbUgxdVAtU1R3bWVHcmVUN1dEdHc5WkU1ZUEwSEV2azJiSUgtT1UtOXpCOGpqU3pkSDRKbEw5YzcyMUFyYk1heW8wdzQ3bzNEUjN4MWpVSndVSWVIek9IdmhUTTAwdHI3Zw?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Evolent Health Inc Class A \u2013 FWB:9EH", "summary": "This page provides financial data for Evolent Health Inc Class A (FWB:9EH) on the Frankfurt Stock Exchange, specifically focusing on its enterprise value to EBIT forward. It indicates that the market is currently closed with no trades recorded. The data is presented within the Tr", "url": "https://www.tradingview.com/symbols/FWB-9EH/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T11:10:50", "published_display": "27 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Evolent Health Inc Class A \u2013 FWB:9EH", "summary": "This article provides the \"Price to sales forward\" metric for Evolent Health Inc Class A (FWB:9EH) on the Frankfurt Stock Exchange. It appears to be a financial data point from TradingView, indicating a specific valuation ratio for the company over a given period, along with its ", "url": "https://www.tradingview.com/symbols/FWB-9EH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T10:11:20", "published_display": "27 Jun 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH)", "summary": "This article provides an overview of Evolent Health, Inc. (EVH) stock, including current market data, analyst forecasts, and detailed financial information. It covers the stock's price performance, market capitalization, earnings, revenue, and EBITDA, along with frequently asked ", "url": "https://www.tradingview.com/symbols/NYSE-EVH/forecast-actuals-and-estimates/?category=cash_flow", "source_name": "TradingView", "published_at": "2026-06-26T03:10:08", "published_display": "26 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health says sale refocuses telehealth business, cuts costs", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0x6M0VNYlFDNFVkamJTZXVTMTNPYU92VG9vYzE4U2JLMlJqM1FYdnQ3dHFOcmt0MlhZSENXekdsSGt3UVFGeVZKaUFrWlNJYThVUmtXOE1ETGdWbDlLYUt1anltSVlrUmg2ZXVpMkp6eG9NZDA1TzJvTXJKbFE2bnJlRm84UWM4MEpMNUZ6RTU5WDRUaXpCU2VGRnNpYk9ERWRCVkZRblBEM2VPdWxTMGhDMEVVM28zbkpYQw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH) and Celldex (CLDX)", "summary": "This article highlights bullish sentiments from financial analysts on three healthcare companies: Amneal Pharmaceuticals (AMRX), Evolent Health (EVH), and Celldex (CLDX). UBS reiterated a Buy rating for Amneal Pharmaceuticals, while Truist Financial maintained a Buy rating for Ev", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CLDX/pressreleases/2453853/analysts-offer-insights-on-healthcare-companies-amneal-pharmaceuticals-amrx-evolent-health-evh-and-celldex-cldx/", "source_name": "The Globe and Mail", "published_at": "2026-06-14T06:40:17", "published_display": "14 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Raises Price Target on Evolent Health to $7 From $6, Keeps Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/truist-raises-price-target-evolent-094013572.html", "source_name": "MT Newswires", "published_at": "2026-06-12T09:40:13+00:00", "published_display": "12 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQZFR4dW9fZzRnSGhnTjljTlVXZnRsWTUwemRBR1ZtTTVBaHVjVkNXUE5DMnhRNG9jd0lPZjZhcWR2elVwemZ1U1FCTTRoZGtBN0VjdGJ5NzlhazlWR0RNOEhCYVZPVWNmVkZvM29fOUZrUGZaXzVRNkh6T3NQTGhmZGN3RWNuaDhPYVU3QkNGS09SUUpmRGRHTnV0dWNkMjVjT1Y2WlpOaE9lNUI1dWc?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units", "summary": "Evolent Health, Inc. director Russell Monroe Glass was granted 41,096 restricted stock units (RSUs) of Class A Common Stock at $0.00 per share under the company\u2019s 2015 Omnibus Incentive Compensation Plan. These RSUs are set to vest on the earlier of June 4, 2027, or the company's", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-947f29717cec.html", "source_name": "Stock Titan", "published_at": "2026-06-11T18:09:22", "published_display": "11 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Evolent Health (EVH) receives 41,096-share RSU grant", "summary": "Evolent Health director Brendan B. Springstubb was granted 41,096 restricted stock units (RSUs) of Class A Common Stock, valued at $0.00 per share, under the company's 2015 Omnibus Incentive Compensation Plan. Following this grant, his direct holdings total 99,917 shares. These R", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-b6bba4b2d6bf.html", "source_name": "Stock Titan", "published_at": "2026-06-09T11:10:10", "published_display": "09 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director receives 41,096 restricted stock units grant", "summary": "Evolent Health, Inc. director Peter J. Grua was granted 41,096 restricted stock units (RSUs) of Class A Common Stock at $0.00 per share, as reported in a Form 4 filing. These RSUs are compensation-related and will vest on the earlier of June 4, 2027, or the company's 2027 annual ", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-58af23ce219f.html", "source_name": "Stock Titan", "published_at": "2026-06-09T03:08:43", "published_display": "09 Jun 2026 03:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units", "summary": "Evolent Health director Kim Keck was granted 41,096 restricted stock units (RSUs) under the company's 2015 Omnibus Incentive Compensation Plan, increasing her direct ownership to 102,597 shares. These RSUs will vest on the earlier of June 4, 2027, or the company\u2019s 2027 annual mee", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-4409002253d4.html", "source_name": "Stock Titan", "published_at": "2026-06-09T02:09:28", "published_display": "09 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings", "summary": "Evolent Health director Craig A. Barbarosh was granted 41,096 restricted stock units (RSUs) as part of the company's 2015 Omnibus Incentive Compensation Plan, at no cash cost. These RSUs are set to vest by June 4, 2027, or the company's 2027 annual meeting, contingent on his cont", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-c04cc6f0a6d7.html", "source_name": "Stock Titan", "published_at": "2026-06-09T00:09:28", "published_display": "09 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director receives 41,096 restricted stock units award", "summary": "Jill D. Smith, a director at Evolent Health (EVH), was granted 41,096 restricted stock units (RSUs) as equity compensation, increasing her total direct holdings to 64,233 shares. These RSUs, part of the 2015 Omnibus Incentive Compensation Plan, will vest on the earlier of June 4,", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-9bd2c919f2aa.html", "source_name": "Stock Titan", "published_at": "2026-06-08T20:09:28", "published_display": "08 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Evolent Health, Inc. Insider Trading Activity", "summary": "Evolent Health, Inc. director Shawn M. Guertin reported receiving an equity award of 41,096 restricted stock units of Class A Common Stock. These units were granted at no cash cost under the company's 2015 Omnibus Incentive Compensation Plan and vest on the earlier of June 4, 202", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-be078ff1f7fb.html", "source_name": "Stock Titan", "published_at": "2026-06-08T20:09:28", "published_display": "08 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant", "summary": "Richard M. Jelinek, a director at Evolent Health (EVH), received an equity grant of 41,096 restricted stock units (RSUs) with no purchase price. These RSUs will vest on the earlier of June 4, 2027, or the company's 2027 annual meeting, provided Jelinek continues his service. Foll", "url": "https://www.stocktitan.net/sec-filings/EVH/form-4-evolent-health-inc-insider-trading-activity-a7b9c359eaff.html", "source_name": "Stock Titan", "published_at": "2026-06-08T20:09:28", "published_display": "08 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) holders back board, auditor and pay plan at 2026 meeting", "summary": "Evolent Health (EVH) stockholders approved all proposals at their 2026 annual meeting, including the election of ten director nominees, the ratification of Deloitte & Touche LLP as their independent registered public accounting firm, and an advisory vote on 2025 executive compens", "url": "https://www.stocktitan.net/sec-filings/EVH/8-k-evolent-health-inc-reports-material-event-170cf49fe7a5.html", "source_name": "Stock Titan", "published_at": "2026-06-04T19:38:39", "published_display": "04 Jun 2026 19:38", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxORE9OaWtsRXhXVG1pb1k1OE55LTR4RXBWbUthTDBzSUMwdEZZcGdhUHNQdmFQeWIwbUlsYWNGZlVHVnNQTFF1Z0ZTUXBmME5tOVI1UjRtbTBkMC1Gc092TFRRUGpRaXJmMnhSTWRFS1FCYkIyeU1FbU5Hc1ZjOGtOZENWOUJuSEdjbGJIQjBPZmNhSy1GRVh1bTRDd0JKLWN3U0VoQi1YZEpjcTBKaUFvMzRxSENzUjdSR1VjT3o3V1gySXJXTHVTdzhzQ1NjWEMybnRNVHJIby1YanRt?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?", "summary": "", "url": "https://finance.yahoo.com/m/dc8aa335-0a27-3c66-b23b-bf6a169ec69b/is-privia-health-stock-a-buy.html", "source_name": "Motley Fool", "published_at": "2026-05-30T20:27:35+00:00", "published_display": "30 May 2026 20:27", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health : EVH", "summary": "Evolent Health Inc. (EVH) specializes in healthcare management, offering services in oncology, cardiology, and musculoskeletal care, backed by its Identifi technology. The company, founded in 2011 and based in Arlington, Virginia, supports health plan administration and provides ", "url": "https://247wallst.com/companies/evh/", "source_name": "24/7 Wall St.", "published_at": "2026-05-20T08:10:38", "published_display": "20 May 2026 08:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts\u2019 Top Healthcare Picks: ProMIS Neurosciences (PMN), Evolent Health (EVH)", "summary": "Analysts from Maxim Group and William Blair have issued bullish sentiments on ProMIS Neurosciences (PMN) and Evolent Health (EVH) respectively. ProMIS Neurosciences received a Buy rating with a $35.00 price target, while Evolent Health also maintained a Buy rating with a consensu", "url": "https://www.theglobeandmail.com/investing/markets/stocks/PMN/pressreleases/1979495/analysts-top-healthcare-picks-promis-neurosciences-pmn-evolent-health-evh/", "source_name": "The Globe and Mail", "published_at": "2026-05-17T04:39:22", "published_display": "17 May 2026 04:39", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Earnings: Here's What Analysts Think", "summary": "Evolent Health, Inc. (NYSE:EVH) recently reported first-quarter earnings, with shares surging 14%. While revenues came in below estimates, statutory losses were smaller than predicted. Analysts maintain a consensus price target of US$5.43, with expectations for significant revenu", "url": "https://www.sahmcapital.com/news/content/evolent-health-inc-nyseevh-just-released-its-first-quarter-earnings-heres-what-analysts-think-2026-05-09", "source_name": "Sahm", "published_at": "2026-05-09T13:40:06", "published_display": "09 May 2026 13:40", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) Narrows Q1 Loss To US$26.6 Million Testing Bullish Margin Narratives", "summary": "Evolent Health (EVH) reported a Q1 2026 net loss of US$26.6 million on US$496.2 million in revenue, narrowing its loss from the previous quarter but still operating in loss-making territory. Analysts anticipate significant long-term margin improvement and profit, heavily relying ", "url": "https://www.sahmcapital.com/news/content/evolent-health-evh-narrows-q1-loss-to-us266-million-testing-bullish-margin-narratives-2026-05-08", "source_name": "Sahm", "published_at": "2026-05-09T01:39:16", "published_display": "09 May 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (NYSE: EVH) trims Q1 2026 loss as revenue tops $496M", "summary": "Evolent Health (NYSE: EVH) reported a narrower net loss of $26.6 million for Q1 2026, a significant improvement from the $72.3 million loss in Q1 2025, with revenue climbing to $496.2 million. The company's basic and diluted loss per share decreased to $0.24, compared to $0.63 in", "url": "https://www.stocktitan.net/sec-filings/EVH/10-q-evolent-health-inc-quarterly-earnings-report-aa4e73d1eb68.html", "source_name": "Stock Titan", "published_at": "2026-05-07T12:39:15", "published_display": "07 May 2026 12:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent (NYSE: EVH) trims Q1 2026 loss as costs rise, keeps outlook", "summary": "Evolent Health, Inc. reported slightly increased Q1 2026 revenue of $496.2 million, with net loss narrowing to $26.6 million. However, adjusted EBITDA declined due to rising medical costs, reflected in a higher medical expense ratio of 93.3%. The company reaffirmed its full-year ", "url": "https://www.stocktitan.net/sec-filings/EVH/8-k-evolent-health-inc-reports-material-event-533eb8fc2fb4.html", "source_name": "Stock Titan", "published_at": "2026-05-07T11:10:16", "published_display": "07 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Evolent Health (EVH) Stock Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQR1ZBTEVDYWhWdjBQd0Nqb0xtQTJCMERqdWtiWmpQX3RscEpMd2hqSmFYUkhlY1hMdDRscWZqQXFLY3JobkQ0VWdxRXgxQl93dVpMOXZtTUxUU3A3c2VDSm1iM25wMUwtRWpqc1FBMlUxOHlrTVFVelBEbmlaVUZNV0NKdDJBTU44YnlaWDFhMlpZMVY3cW5yZWtDb1ZFTGJGMGZkNUVIaw?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOZmxLUHpkdHI0UnIyTjZXa0tmUklocXVQUVNxOEpGY0s2SmRtTlR4UTB1T0lhTnFiRVl4b3RBVkNoTkpQNFBYQTBEYnItT043dFY0SFVEd2NleE0xVGEtOGhkNWxtbTFHRWwwOEpoSHo0NnBqUnFuTU44S2lBY240UUhhS0t5a2JaSmpuTU8tUnFZVnN0SW5SS3lmbTJCanRrVXM5MXFrRkRoa25YTENDRUprYkVSQXBqMllqMFJHRHhsMDVRelZjdVVmZDloT1phdThDWklR?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Announces First Quarter 2026 Results", "summary": "Evolent Health, Inc. announced its financial results for the first quarter ended March 31, 2026, reporting revenue of $496.2 million and a net loss attributable to common shareholders of $26.6 million. Despite a net loss, the company reiterates its full-year 2026 revenue guidance", "url": "https://www.sahmcapital.com/news/content/evolent-announces-first-quarter-2026-results-2026-05-07", "source_name": "Sahm", "published_at": "2026-05-06T17:39:18", "published_display": "06 May 2026 17:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Evolent Health (EVH) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQT210WUZxQ2tXcmJURVpCZ2ZuOUhRTFQtZk9EZm9JM0pLX2dWaXYzT1pJaE5ObjdNcTh1dnNFNkFVMFF2Y3BnaEo1OTA3Y21tZ2owY3pOZE52Q2l6T1BjVWVnX2xqR3RKbHA2UDdESExQNkM5dHRPWXRkbjlXel9FWnZKb3RpVjdIbDk5SlRCdGZyN3FQMkpfMQ?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxOb1JsNjROdDgwZm1PaXVMSWhxM0hTd216cXBYU0xTQmNKQm8zU2I0bzdyUTdBRVJ5STd1eDA1cEhQQk1oVk1WNnFRMVhvajVwZjZ4d3Z4UERabUxORFlYNzFUMXowSXFWb1d1dWZmcUUwRnR3cjBRc0VEaTctQVlOc25lMWpwVk1qR3lwUTRtT2Fuel9acHFvaGNVSzVIcF8wZTcwUFY2OTFaWTd3cnlfSjRVS0NveUtsV1Y4ZGZSZFp3OXNoX2kwNnc4X3ZBbmtsbTVCMFJyZVNRQ3cwVVphdm9B?oc=5", "source_name": "StockStory", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxQanFhNFBobUhvWlBzcGxQN21VUzlqZW45RmtYWk1sbTVnSUxiTWxScHd3MTRQTzJUak9uVjd0UWZiSFExMmlUNW9wekdBb3pmZ0JsRlI5MXRwOTJiYzM5Y2ZnNXVFblRzMTdCVFg0eEM3TGxvckdGcnZxZGxzVl9PZW5DbDR3N2R5RHlyeHhKSUxublE3MzRScDUzVWdEUVgtdVdEMVhBMHhmVHlxQ2RzTjJaUXZ2cHJYQU1fS0dpMldJLXhLSDZjNW5TUTRmbDk2LWRPQWM5TjZTSzB6bHJFeC1nVHl3TV9ncTRHandYUk96U28?oc=5", "source_name": "StockStory", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026", "summary": "Evolent Health, Inc. (NYSE: EVH) announced that it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open. A conference call for shareholders and interested participants will follow at 8 a.m. ET, accessible via Evolent's investor relati", "url": "https://www.sahmcapital.com/news/content/evolent-to-release-first-quarter-2026-financial-results-on-thursday-may-7-2026-2026-04-07", "source_name": "Sahm", "published_at": "2026-04-08T12:40:02", "published_display": "08 Apr 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQbmJvTlduSGVKcFlkS0paQWdDTVA2cHNBbTBNYnlfN25QOHpDX0NtUFRjSmF5MjJLbWw4al9sbFNMT3FrOE9IeThaZkExMkFZNVUxem9CNktXMk9RSjJ6R3hsa1ZLVFBnUlR5c25aNXk0cFZ1UkM2b2U3THdfeFA2cGNIMGl2R3BwQlJuV1Rld1ctcFUxNTJz?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxQWndTWUFkaVhCWkFYMUQ0UkdvQjZTUUJJZ2V6dUdBZUwxNjlySGliOF9PTlRkS2tsRWNXcG9MRjJnT1pYTERyTTh6T09veW0tVUl2Q1ZkM1dQVGpsRUVsdDR3eDBJc3h6NkllZEtpcHJ4NnVaUVpOQmt5LWRLNnB5cHZCU0VqNWxMaFQ5VFg0YWNVbFV5eV81NUlyVW85TzJHQlQwWnFn?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G/A] Evolent Health, Inc. Amended Passive Investment Disclosure", "summary": "The Vanguard Group filed an Amendment No. 8 to a Schedule 13G/A for Evolent Health, Inc. (EVH), reporting that its beneficial ownership is now 0 shares (0%) due to an internal realignment. This realignment, effective January 12, 2026, means certain Vanguard subsidiaries will now ", "url": "https://www.stocktitan.net/sec-filings/EVH/schedule-13g-a-evolent-health-inc-amended-passive-investment-disclosu-7b06abf5039f.html", "source_name": "Stock Titan", "published_at": "2026-03-24T11:41:06", "published_display": "24 Mar 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent announces appointment of Archie Mayani as chief product officer", "summary": "Evolent Health, Inc. has announced the appointment of Archie Mayani as Chief Product Officer. Mayani brings over two decades of experience in healthcare technology and AI, having previously held leadership roles at GHX, Change Healthcare, UnitedHealth Group, and Amazon. Her exper", "url": "https://www.sahmcapital.com/news/content/evolent-announces-appointment-of-archie-mayani-as-chief-product-officer-2026-03-19", "source_name": "Sahm", "published_at": "2026-03-19T17:41:19", "published_display": "19 Mar 2026 17:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Small-Cap Stock Risks: Declining Demand at Luxfer & Financial Strain at Evolent Health - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORTA5dFl6TEJhaEhhTVdpU0hsdnR5SkxxcGtZWWQwaEV2dWV2ZEVSazVqYmhwdmhxMnh5MXE2ZFFrNjFaMUl6aXc0M3hIcS1VSUhXeGFucW1ZbF91czd0QkhCLTF2Nl9oMlhTUlN1dU81UG1SZEFoQUZXVTU4ZFVtM2dzckMyLXpUY3FQdGduRkVqTkJ4TTNMQV9QV1VGb0VvTGoyX0hvaDVyMXNOV1UzSG05RFQ4cHc?oc=5", "source_name": "IndexBox", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EVH Stock Price, Quote & Chart | EVOLENT HEALTH INC - A (NYSE:EVH)", "summary": "This article provides an overview of Evolent Health Inc. (EVH) stock, including its current price of $2.99, recent performance, and key financial metrics. The company reported Q4 earnings recently, beating EPS expectations but missing revenue, and analysts forecast a significant ", "url": "https://www.chartmill.com/stock/quote/EVH/profile", "source_name": "ChartMill", "published_at": "2026-03-12T23:51:34", "published_display": "12 Mar 2026 23:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How to listen to Health Catalyst\u2019s March 12 results call", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOT3JfOVF2X3hWZ1BFdmRQVHVCalJuSlRGR1A4Vm1zYml0X2t5WkZKNjlFNy1PcWR1djlBZjdPb0ZrVEtURXBCVWhsaHAwWEoxalUxdzZqOEE4V3lBYU9qTk1MZW5WMjduOWNJd25UOXBKR0FyNDdyQXdpMmNrRnIyS2ZRVDZSOVFTZVYya2Z1RzlFdEY5dzlxMmNnaWY5OGUzdnZEVWtsTktlMERWM1ZjMVNXUHJFQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) Shares Skyrocket, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOZDRtelRVWHNsMS1wcEN5SjJvZ3dyYkRnTzV6bUNVajZTaGxxa3BPRGdseTlSYW1WeGVPVlVpSmNPRVF0SlMtRkFXdVVVUmFyN05YV3JFQVM2ck9CeXZWMkQ4bEVWQkg2c0RET1NkZ0hFQTcxOEg3MTVnUE9aS3VUVjZIb3dqQmxN?oc=5", "source_name": "Market source", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH) Reports Q4: Everything You Need To Know Ahead Of Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQZ1I5MEdnMC1PazYyZUYtMFBSV2hsaTdrRjVNaGNJRzdzS3Fzb3ljeUhZUGFrczJOdEdDYXdQWUhFQzVwY1BPX3l1cmRDR3NydjZVR1B3N3U2RHhqY3ZpRjROZWJHN2dTeDl0MUFvR3pFRUo0em5PNzItTzhFMjM4cA?oc=5", "source_name": "Market source", "published_at": "2026-02-22T08:00:00+00:00", "published_display": "22 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNSjhLcktHSzEyOEMtaEZpeFlFb0FuWV9UZ0FwRHJ4enVRbVdwQkszVmlRMXZvdnR3dGZ5Q3JhNVhVT3VscXNRSFR2MjNSTy1BZjhTcE1yd3M0d1hialRTT3d2bmkyY3NxSFJhRTVUa1hxX1dXRVpwZ3FHSnN5a28tNmM3aUc?oc=5", "source_name": "Market source", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health, Inc. - Class A Shares (EVH) Stock Price Today: $5.63", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE1UNFMtbW1TMFphRVZHRW1hN0M0T05hVEdtVTFVa1VuVkVURU85Z2ZJSjU0dENwaG5raVBiTjViVjdqdGFTUnpuWjBWY1JienF0djdTRVN3?oc=5", "source_name": "Gotrade", "published_at": "2026-02-03T07:00:20+00:00", "published_display": "03 Feb 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Take Care Before Diving Into The Deep End On Evolent Health, Inc. (NYSE:EVH)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Evolent Health (EVH) Shares Are Sliding Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOX3h1eDU4aDRMM0FNNzNDNDAxS0M3R2tkMGJ4YjdhS2VUZVJmV1VicmFJVzh0eGRjZlVwUk9Xd3g5S1pxRzRWT0toTWRwTm45WmcwUHNxVVdqaXhVSENQNEVNaExKTUlidVBYOWF3aEVJNXU0MTV2NXpYVzhUUzE5cA?oc=5", "source_name": "Market source", "published_at": "2025-11-19T08:00:00+00:00", "published_display": "19 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPcGNGXzF5eUNGZ3NIVDBaMXFNLTlnUEFBajJZTFJhVUM0a3ZUNXZWZy1HYXBYdkV1dmNScFZWbTJNbldFVjVFU0dTenVRc1lGeGNIUS1iNV9uSm5acGE1cmhsQ2N5NGxTME9MUHJuT01kLXJXRmgtV1hQekNZMUR0VzFxaHVsSXQ0dndadEVFSmNvSzEzNlF1MUlGVFlyWHJYTE0zVFgxZUsydG5QU0JBUEFfY1RZeUZRLUZidmJCdkhBYTVfRnFzZnNiWmZnTEh5ZXdvR2NKMXBHRXVYT2dKcDUwUF9VUmNKX0NpQUlrYw?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywJBVV95cUxPSzBJWkN5TnV1U2VfR0F6ODh5UW9qYzdVcmxhQzNZZ1VuWm5sd1JKcUcyMld4SjJ1ZGlGSF83WHVVU3lJWkpRVGF1R2NOQmJKOTNiUUtYVWlTbTAzeTBGQk9JWXJrd1BZcXJMdFMzNmpQNGd5NWRWejUwWXBLNUhISFJQalhmZHoxa1RZQW5tWXl3eUFsUUZoWXh5Mm10TXJUOTRObUJZenQ0UjJiLWp1NDdFZ3k0RS05bWRUUzE3Q3llZTNaRmNEN1oyWUFMUEQ2VVFRN2FrNUZKcExReE95eVBaYkd4ZTR0eFJxTHJ2OWx2X1R1TjlXeXVzQzZmS25McUJmM201TnIwamlvdEo4VV9vdndjRktORjJVWXQ1eUF1eGdRUW9NQ2ROQ2NNYlBDWXc3LU9QR1djaE9oMFd6SUdIazkwVVgtN05R?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-19T07:00:00+00:00", "published_display": "19 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Evolent Health (EVH) Stock Is Nosediving", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNVFZkLTI5M0x3X1hwTzBMU1hIOVJRaTV5cEE0eHlhNVFxRUhMSXRLQmQxMFNDdVA0VV9CTUYtUjBfb0lsQkFXMWxJemJqRmpjMDdhS1RacHVmZnFDT3BaWWMtbzRvd09YODVnQlIzR0oyNWFxVEZENDEtOTNvczBwdzNtNXNpQ25reUhMUFFyemphV2k5dTFhOU8xa0I2NVlRRVpV?oc=5", "source_name": "StockStory", "published_at": "2025-08-08T07:00:00+00:00", "published_display": "08 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Privia Health Announces Q2 2025 Earnings Call: Key Details for August 7 Pre-Market Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPcDdGajBYcnBKZERVcy00Ym9aaEx1cFNWYXhUdmxmY0t5R1B5bUUxQnBGTUl1dndCSGZkeUZUS3pZaERfVmhEVjd3TlZBMzduaVFrWjNKaFowNVpydmpQNXpaaS1Rc1Nwb1czekROUFcwem91SmNSSzNMZUFEOU80TDd0eG1SQVlaeEZSY25PbzlvWDNiek9sN3UtZWJjM0ZBUkdpNHd2eUVEQUFDaVF2VUc2WUZLTHRyUnc?oc=5", "source_name": "Stock Titan", "published_at": "2025-07-10T07:00:00+00:00", "published_display": "10 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Streamline Health Solutions In (STRM) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2QmlFQ3laVE9oMXFKazhkeFZOM2FUQ0pGVUthUFlJRGQ3U1dkSXJmcXhoZXpfQi1JbTVJdEgtbmJZWVcyNVdENzNLZ21XOXdRZXhF?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T04:54:57+00:00", "published_display": "25 Apr 2025 04:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 104, "total_relevant": 66, "sentiment_summary": {"positive": 12, "negative": 3, "neutral": 51, "score": 53, "total": 66, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 21.45, "count": 39}, {"event": "earnings", "label": "Earnings", "weight": 10.45, "count": 19}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 5.88, "latest_week": "2026-07-10", "one_week_move": 3.0, "four_week_move": 22.5, "twelve_week_move": 107.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.386365, "market_dynamics_buy_signal": false, "relative_strength": -2.200604, "fair_value_gap": -63.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.8031, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.0% over one week, +22.5% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 21}, {"label": "Market source", "count": 10}, {"label": "Sahm", "count": 6}, {"label": "StockStory", "count": 5}, {"label": "TradingView", "count": 3}, {"label": "MT Newswires", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "PR Newswire", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 66}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 39}, {"label": "Earnings", "count": 19}, {"label": "Analyst action", "count": 4}, {"label": "Balance sheet", "count": 2}, {"label": "Macro sensitivity", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "66", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+3.0% over one week, +22.5% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026"}], "updated_at": "2026-07-16T00:49:57.651794+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}